Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cosentino

Showing results (1-10 of 304) with videos related to

Pageof 31
Sort By:
Recenti Progressi in Medicina|November 19, 2003
[Statins in cardiovascular disease. Role of Rho/Rho kinase inhibition and of Akt activation ]Francesco Cosentino
Current Vascular Pharmacology|December 25, 2012
Proceedings of the Symposium "Cardiometabolic Risk and Vascular Disease--From Mechanisms to Treatment"Francesco Cosentino
Clinical Hemorheology and Microcirculation|July 21, 2007
Aging and endothelial dysfunctionFrancesco Cosentino, Elena Osto
Journal of Hypertension|August 27, 2002
Antihypertensive effect and end-organ protection of flavonoids: some insights, more questionsFrancesco Cosentino, Massimo Volpe
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 19, 2019
The combination of coronary artery disease and type 2 diabetes: a therapeutic challengeIsabelle Johansson, Francesco Cosentino
Current Hypertension Reports|February 3, 2005
Hypertension, stroke, and endotheliumFrancesco Cosentino, Massimo Volpe
European Heart Journal|November 2, 2013
Advanced glycation endproducts and plaque instability: a link beyond diabetesFrancesco Paneni, Francesco Cosentino
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2021
SGLT2i: new perspectives in diabetes and kidney diseaseGiulia Ferrannini, Francesco Cosentino
Current Vascular Pharmacology|December 25, 2012
p66 Shc as the engine of vascular agingFrancesco Paneni, Francesco Cosentino
European Journal of Preventive Cardiology|November 27, 2019
Cardio-diabetology: The new 'sweetheart' in cardiovascular preventionVictor Aboyans, Francesco Cosentino
Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
Recenti Progressi in Medicina|November 19, 2003
[Statins in cardiovascular disease. Role of Rho/Rho kinase inhibition and of Akt activation ]Francesco Cosentino
Current Vascular Pharmacology|December 25, 2012
Proceedings of the Symposium "Cardiometabolic Risk and Vascular Disease--From Mechanisms to Treatment"Francesco Cosentino
Clinical Hemorheology and Microcirculation|July 21, 2007
Aging and endothelial dysfunctionFrancesco Cosentino, Elena Osto
Journal of Hypertension|August 27, 2002
Antihypertensive effect and end-organ protection of flavonoids: some insights, more questionsFrancesco Cosentino, Massimo Volpe
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 19, 2019
The combination of coronary artery disease and type 2 diabetes: a therapeutic challengeIsabelle Johansson, Francesco Cosentino
Current Hypertension Reports|February 3, 2005
Hypertension, stroke, and endotheliumFrancesco Cosentino, Massimo Volpe
European Heart Journal|November 2, 2013
Advanced glycation endproducts and plaque instability: a link beyond diabetesFrancesco Paneni, Francesco Cosentino
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2021
SGLT2i: new perspectives in diabetes and kidney diseaseGiulia Ferrannini, Francesco Cosentino
Current Vascular Pharmacology|December 25, 2012
p66 Shc as the engine of vascular agingFrancesco Paneni, Francesco Cosentino
European Journal of Preventive Cardiology|November 27, 2019
Cardio-diabetology: The new 'sweetheart' in cardiovascular preventionVictor Aboyans, Francesco Cosentino
Pageof 31